ZIVO Bioscience (ZIVO) Competitors

Evaxion Biotech A/S (NASDAQ:EVAX) and ZIVO Bioscience (NASDAQ:ZIVO) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, profitability, earnings, media sentiment, dividends, analyst recommendations, community ranking and institutional ownership.

Do analysts recommend EVAX or ZIVO?

Evaxion Biotech A/S currently has a consensus price target of $11.00, suggesting a potential upside of 195.70%. Given ZIVO Bioscience's higher probable upside, analysts clearly believe Evaxion Biotech A/S is more favorable than ZIVO Bioscience.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Evaxion Biotech A/S	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
ZIVO Bioscience	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Does the MarketBeat Community favor EVAX or ZIVO?

ZIVO Bioscience received 82 more outperform votes than Evaxion Biotech A/S when rated by MarketBeat users. Likewise, 61.11% of users gave ZIVO Bioscience an outperform vote while only 56.67% of users gave Evaxion Biotech A/S an outperform vote.

Company	Underperform	Outperform
Evaxion Biotech A/S	Outperform Votes 17 56.67%	Underperform Votes 13 43.33%
ZIVO Bioscience	Outperform Votes 99 61.11%	Underperform Votes 63 38.89%

Is EVAX or ZIVO more profitable?

Evaxion Biotech A/S has a net margin of 0.00% compared to Evaxion Biotech A/S's net margin of -11,068.75%. Evaxion Biotech A/S's return on equity of 0.00% beat ZIVO Bioscience's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Evaxion Biotech A/S	N/A	-451.63%	-149.27%
ZIVO Bioscience	-11,068.75%	N/A	-677.15%

Which has better earnings and valuation, EVAX or ZIVO?

ZIVO Bioscience has lower revenue, but higher earnings than Evaxion Biotech A/S. ZIVO Bioscience is trading at a lower price-to-earnings ratio than Evaxion Biotech A/S, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Evaxion Biotech A/S	$70K	287.50	-$22.12M	-$6.76	-0.55
ZIVO Bioscience	$30K	750.12	-$7.78M	-$3.80	-2.10

Do institutionals and insiders hold more shares of EVAX or ZIVO?

11.0% of Evaxion Biotech A/S shares are held by institutional investors. Comparatively, 12.8% of ZIVO Bioscience shares are held by institutional investors. 41.6% of Evaxion Biotech A/S shares are held by insiders. Comparatively, 13.4% of ZIVO Bioscience shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Does the media favor EVAX or ZIVO?

In the previous week, ZIVO Bioscience had 2 more articles in the media than Evaxion Biotech A/S. MarketBeat recorded 2 mentions for ZIVO Bioscience and 0 mentions for Evaxion Biotech A/S. Evaxion Biotech A/S's average media sentiment score of 1.38 beat ZIVO Bioscience's score of 0.00 indicating that ZIVO Bioscience is being referred to more favorably in the news media.

Company	Overall Sentiment
Evaxion Biotech A/S	Neutral
ZIVO Bioscience	Positive

Which has more risk & volatility, EVAX or ZIVO?

Evaxion Biotech A/S has a beta of -0.22, indicating that its share price is 122% less volatile than the S&P 500. Comparatively, ZIVO Bioscience has a beta of 0.26, indicating that its share price is 74% less volatile than the S&P 500.

Summary

ZIVO Bioscience beats Evaxion Biotech A/S on 10 of the 17 factors compared between the two stocks.